We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Orthoss® Collagen

Orthoss Collagen is a highly purified natural bone mineral combined with native collagen, designed for orthopedic bone regeneration. Granules of cancellous bone mineral provide an osteoconductive matrix for bone regeneration. Natural collagen makes this composite material malleable.

Specially Combined for Bone Regeneration

Orthoss Collagen is a composite material characterized by a bimodal pore structure of micropores and macropores with high interconnectivity. 1 This structure gives Orthoss Collagen a large surface area, plus wettability and fluid retention capacity. 1

The collagen part of the material is resorbed within 1-3 months. Meanwhile, the slow resorption rate of the mineral scaffold provides a protective environment and volume maintenance during bone ingrowth.2,3

The large inner surface also results in exceptional osteoconductivity and osseointegration. The biofunctionality of the natural material further enhances bone ingrowth and vascularization.4,5,6,7

Key Features

 

How to Use Orthoss Collagen

Orthoss Collagen must be used wet.

Do not use more than 3 blocks of Orthoss Collagen per defect.

  

 

References:

  1. Data on file at Geistlich Pharma AG, Wolhusen, Switzerland.(Bench Test)
  2. Araujo, MG. et al. (2009). Clin Oral Impl Res. 21: 55-64.(Pre-clinical)
  3. Schlegel, KA et al. (2003). Int J Oral Maxillofac Implants.18(1): 53-8.(Pre-clinical)
  4. Schlickewei, W. et al. Hefte zur Unfallkunde,216,(1991).(Case series)
  5. Bereiter, H. et al. (1991). Hefte zur Unfallkunde,216.(Expert opinion)
  6. Rohner, D. et al. (2013). Int J Oral Maxillofac Surg. 42(5): 585-91.(Case series)
  7. Trevisiol, L. et al. (2012). J Craniofac Surg. 23(5): 1343-8.(Case series)
  8. Nandi, SK. et al. (2010). Indian J Med Res. 132: 15–30.(Review)

 

 

  

Dr. Sanja Saftic
International Product Manager